Li-Fraumeni Syndrome/TP53 Biobank
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04367246 |
|
Recruitment Status :
Recruiting
First Posted : April 29, 2020
Last Update Posted : February 27, 2023
|
Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborator:
Children's Hospital of Philadelphia
Information provided by (Responsible Party):
Kara Maxwell, Abramson Cancer Center at Penn Medicine
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 24, 2024 |
| Estimated Study Completion Date : | September 24, 2024 |